» Articles » PMID: 26973015

High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2016 Mar 15
PMID 26973015
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies reported an association of diabetes mellitus (DM) with TB susceptibility. Many studies were retrospective, had weak diagnostic criteria for DM, and did not assess other comorbidities. The Effects of Diabetes on Tuberculosis Severity (EDOTS) study is addressing these limitations with a longitudinal comparison of patients with TB who are classified as diabetic or normoglycemic according to World Health Organization criteria. We report interim findings after enrolling 159 of a planned 300 subjects.

Methods: A cohort study of patients with TB in South India with DM or normoglycemia defined by oral glucose tolerance test (OGTT) and fasting glucose. Glycohemoglobin (HbA1c), serum creatinine, lipids, and 25-hydroxyvitamin D were measured at enrollment. Patients were monitored monthly during TB treatment, and HbA1c measurement was repeated after 3 months.

Results: Of 209 eligible patients, 113 (54.1%) were classified as diabetic, 44 (21.0%) with impaired glucose tolerance, and 52 (24.9%) as normoglycemic. More patients with diabetes were detected by OGTT than by HbA1c. Diabetes was a newly received diagnosis for 37 (32.7%) in the DM group, and their median HbA1c (6.8%) was significantly lower than in those with previously diagnosed DM (HbA1c, 10.4%). Among 129 patients monitored for 3 months, HbA1c declined in all groups, with the greatest difference in patients with a newly received diagnosis of DM.

Conclusions: Early EDOTS study results reveal a strikingly high prevalence of glycemic disorders in South Indian patients with pulmonary TB and unexpected heterogeneity within the patient population with diabetes and TB. This glycemic control heterogeneity has implications for the TB-DM interaction and the interpretation of TB studies relying exclusively on HbA1c to define diabetic status.

Citing Articles

Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes.

Nancy Pandiarajan A, Kumar N, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S Pathogens. 2025; 14(2).

PMID: 40005523 PMC: 11857862. DOI: 10.3390/pathogens14020146.


The Complex Relationship Between Tuberculosis and Hyperglycemia.

Byers M, Guy E Diagnostics (Basel). 2024; 14(22).

PMID: 39594205 PMC: 11593071. DOI: 10.3390/diagnostics14222539.


Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.

Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L Exploration (Beijing). 2024; 4(5):20230138.

PMID: 39439490 PMC: 11491313. DOI: 10.1002/EXP.20230138.


HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis.

Salindri A, Kipiani M, Lomtadze N, Tukvadze N, Avaliani Z, Blumberg H Sci Rep. 2024; 14(1):23834.

PMID: 39394335 PMC: 11470076. DOI: 10.1038/s41598-024-68605-2.


Prior tuberculosis, radiographic lung abnormalities and prevalent diabetes in rural South Africa.

Castle A, Moosa Y, Claassen H, Shenoi S, Magodoro I, Manne-Goehler J BMC Infect Dis. 2024; 24(1):690.

PMID: 38992607 PMC: 11238449. DOI: 10.1186/s12879-024-09583-8.


References
1.
Anjana R, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R . Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011; 54(12):3022-7. DOI: 10.1007/s00125-011-2291-5. View

2.
Jeon C, Murray M . Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7):e152. PMC: 2459204. DOI: 10.1371/journal.pmed.0050152. View

3.
Singhal A, Jie L, Kumar P, Hong G, Leow M, Paleja B . Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014; 6(263):263ra159. DOI: 10.1126/scitranslmed.3009885. View

4.
Skerry C, Pinn M, Bruiners N, Pine R, Gennaro M, Karakousis P . Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. J Antimicrob Chemother. 2014; 69(9):2453-7. PMC: 4184365. DOI: 10.1093/jac/dku166. View

5.
Pasipanodya J, McNabb S, Hilsenrath P, Bae S, Lykens K, Vecino E . Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010; 10:259. PMC: 2894771. DOI: 10.1186/1471-2458-10-259. View